This Week in Managed Care: June 27, 2015
This week the Supreme Court ruled in favor of the government in King v. Burwell, preserving access to healthcare subsidies for millions of Americans, and the high cost of cancer drug was in the spotlight.
The top story of the week came Thursday when the Supreme Court delivered its opinion on King v. Burwell.
In the span of 1 week, the cost of cancer drugs has come up twice. First, Memorial Sloan Kettering Cancer Center, led by the efforts of Peter B. Bach, MD, MAPP,
Finally, researchers
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025